STARR CHRISTOPHER M

Director at RAPTOR PHARMACEUTICALS CORP. · on record since May 31, 2006
10% owner at RAPTOR PHARMACEUTICALS CORP. · on record since May 31, 2006
SVP, Chief Scientific Officer at BIOMARIN PHARMACEUTICAL INC · on record since Apr 2, 2004
Director at HORIZON PHARMACEUTICAL LLC · on record since Oct 9, 2009
Chief Executive Officer at HORIZON PHARMACEUTICAL LLC · on record since Oct 9, 2009
Chief Executive Officer at RAPTOR PHARMACEUTICALS CORP. · on record since Nov 23, 2010
Director at Monopar Therapeutics · on record since Jan 8, 2018

Insider trading activity of STARR CHRISTOPHER M

Transactions on record: 209; since Aug 22, 2003

Open-market buys: 0

Open-market sells: 52; $8.1M

Companies traded: 4; last filing Dec 8, 2025

Figures computed from official regulatory filings — .

Companies where STARR CHRISTOPHER M has traded

Monopar Therapeutics51 tx · $672.2K · Oct 5, 2026
RAPTOR PHARMACEUTICALS CORP.143 tx · $15.3M · Oct 26, 2016
HORIZON PHARMACEUTICAL LLC2 tx · $7K · Oct 1, 2009
BIOMARIN PHARMACEUTICAL INC18 tx · $759.4K · Dec 2, 2005

Track record of STARR CHRISTOPHER M

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of STARR CHRISTOPHER M

Co-insiders of STARR CHRISTOPHER M

Anderson RaymondHORIZON PHARMACEUTICAL LLC +2

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-2,970	78.82 USD	$234.1K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-4,631	78.09 USD	$361.6K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Exercise	8,400	0.01 USD	$42		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-799	79.67 USD	$63.7K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	ExerciseD (derivative)	-8,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Dec 8, 2025	AwardD (derivative)	2,924	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	Other	16,800	0.01 USD	$168		SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	Sell	-16,800	40.00 USD	$672K	Unusual size	SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	OtherD (derivative)	-16,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Mar 7, 2025	AwardD (derivative)	11,365	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jan 3, 2024	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Jan 3, 2024	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Oct 3, 2023	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Oct 3, 2023	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 3, 2023	ExerciseD (derivative)	-2,534	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 3, 2023	Exercise	2,534	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Apr 4, 2023	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Apr 4, 2023	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Feb 3, 2023	AwardD (derivative)	13,930	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Feb 3, 2023	AwardD (derivative)	10,133	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jan 3, 2023	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Jan 3, 2023	ExerciseD (derivative)	-2,859	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Oct 3, 2022	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Oct 3, 2022	ExerciseD (derivative)	-2,859	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 1, 2022	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-2,970	78.82 USD	$234.1K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-4,631	78.09 USD	$361.6K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Exercise	8,400	0.01 USD	$42		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	Sell	-799	79.67 USD	$63.7K		SEC
Monopar TherapeuticsListing on record	Oct 5, 2026	ExerciseD (derivative)	-8,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Dec 8, 2025	AwardD (derivative)	2,924	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	Other	16,800	0.01 USD	$168		SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	Sell	-16,800	40.00 USD	$672K	Unusual size	SEC
Monopar TherapeuticsListing on record	Jul 16, 2025	OtherD (derivative)	-16,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Mar 7, 2025	AwardD (derivative)	11,365	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jan 3, 2024	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Jan 3, 2024	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Oct 3, 2023	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Oct 3, 2023	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 3, 2023	ExerciseD (derivative)	-2,534	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 3, 2023	Exercise	2,534	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Apr 4, 2023	ExerciseD (derivative)	-2,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Apr 4, 2023	Exercise	2,533	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Feb 3, 2023	AwardD (derivative)	13,930	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Feb 3, 2023	AwardD (derivative)	10,133	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jan 3, 2023	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Jan 3, 2023	ExerciseD (derivative)	-2,859	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Oct 3, 2022	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC
Monopar TherapeuticsListing on record	Oct 3, 2022	ExerciseD (derivative)	-2,859	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Monopar TherapeuticsListing on record	Jul 1, 2022	Exercise	2,859	—	n/a (No price was disclosed in the filing)		SEC